Should dopamine agonist treatment for prolactinomas be life-long?
Clin Endocrinol (Oxf)
.
1991 Mar;34(3):173-4.
doi: 10.1111/j.1365-2265.1991.tb00288.x.
Author
G Faglia
1
Affiliation
1
Institute of Endocrine Sciences, University of Milan, Milano, Italy.
PMID:
1674680
DOI:
10.1111/j.1365-2265.1991.tb00288.x
No abstract available
Publication types
Comment
MeSH terms
Dopamine Agents / administration & dosage
Dopamine Agents / therapeutic use*
Drug Administration Schedule
Humans
Pituitary Neoplasms / drug therapy*
Prolactinoma / drug therapy*
Substances
Dopamine Agents